Clinical Focus


  • Anatomic and Clinical Pathology

Academic Appointments


  • Clinical Professor, Pathology

Professional Education


  • Board Certification: American Board of Pathology, Anatomic Pathology (2003)
  • Residency: Brigham and Women's Hospital (2002) MA
  • Fellowship: Brigham and Women's Hospital Dept of Pathology (2004) MA
  • Board Certification: American Board of Pathology, Cytopathology (2003)
  • Fellowship: Brigham and Women's Hospital Dept of Pathology (2003) MA
  • Medical Education: Shanghai Medical University (1988) China

All Publications


  • Sarcomatoid malignancies with strong PD-L1 expression often represent dedifferentiated or undifferentiated melanomas. Human pathology Gilbert, A. D., Brown, R. A., Twa, D. D., Lee, A. Q., Hao, C., Lau, H. D., Gross, J. M., Bui, N., Qian, X., Dong, F., Charville, G. W. 2026: 106264

    Abstract

    Despite recent studies showing that dedifferentiated and undifferentiated melanoma (DM/UM) mimic sarcoma histologically, DM/UM continue to pose a diagnostic challenge owing to their under-recognition and frequent misclassification. To address this pitfall, we studied 22 cases of DM/UM initially classified as sarcoma. The patients were typically male (18/22) and older than 55 years (median 65 years, range 40-89 years), often lacking a history of melanoma (15/22). All but one case (21/22) presented with evidence of metastasis, and sites of disease frequently included lymph node basins, especially axilla (10/22). The tumors variably showed spindled and rhabdoid cytomorphology, collagenous or myxoid stroma, and fascicular architecture, imitating sarcoma; all tumors exhibited an intratumoral inflammatory component ranging from moderate to brisk. Molecular testing demonstrated alterations involving BRAF (7/22), NRAS/HRAS (10/22), NF1 (4/14), and TERT promoter (9/13). High tumor mutational burden was present in 13/13 cases (mean 21.8 mutations/Mb) and a UV-related mutational signature was found in 8/8. By immunohistochemistry, 55% (12/22) were negative for melanocytic markers, in keeping with undifferentiated melanoma. Two cases (2/17) were positive for desmin, while SATB2 was positive in 2/2 cases, including one with osteoid. The cohort showed strong expression of PD-L1 in all 22 cases (CPS 80-100, mean 93). In contrast, a separate cohort of 87 sarcomas of varying histotype had an average CPS of 5.6 (median CPS 0), including only three cases with CPS >50. Ten patients received PD-L1-targeted immunotherapy with partial or complete response in 80%. These findings emphasize pitfalls in distinguishing DM/UM from sarcoma and highlight the utility of PD-L1 immunohistochemistry in accurately diagnosing and effectively treating DM/UM.

    View details for DOI 10.1016/j.humpath.2026.106264

    View details for PubMedID 42716382

  • Updates on Soft Tissue Cytopathology: Focusing on New and Provisional Entities, Distinct Types, New Diagnostic Tools, and Evolving Concepts. Acta cytologica Rekhi, B., Qian, X., Field, A. S. 2026: 1

    Abstract

    The first edition of the World Health Organization (WHO) reporting system for soft tissue cytopathology (WHO system) has been released recently, providing a framework of 6 categories with their individual risk of malignancies. The 6th edition of the WHO tumours of soft tissue and bone is in the pipeline, including "provisional" tumour entities, reflecting developments in the identification of new entities, particularly based on high-throughput molecular techniques and immunohistochemical stains, including surrogates to the underlying molecular signatures, along with an evolution of tumour concepts.This review focuses on some of these recently identified and provisional soft tissue tumours; newly described immunohistochemical stains and concepts. The cytopathological features of various soft tissue tumours discussed in this include sarcomas with BCOR alterations, CIC rearranged sarcomas, pseudoendocrine sarcoma, MYOD1-positive spindle cell/sclerosing rhabdomyosarcoma, superficial CD34-positive pleomorphic fibroblastic tumour, pseudomyogenic haemangioendothelioma, chondroid synoviocytic neoplasm, and others.This would contribute to the expanding and evolving cytopathological spectrum of soft tissue tumours, including sarcomas, including the value addition of certain more specific immunostains and molecular tests.

    View details for DOI 10.1159/acy/abjag008

    View details for PubMedID 42704753

  • Fibromyxoid Nephrogenic Adenoma Mimicking Renal Cell Carcinoma: A Diagnostic Pitfall in Fine-Needle Aspiration Cytology. Diagnostic cytopathology Gedallovich, J., Adeniyi, A., Sangoi, A. R., Qian, X., Ernst, K. 2026

    Abstract

    Nephrogenic adenoma (NA) is a benign lesion of the genitourinary tract that may mimic malignancy both clinically and histologically. The fibromyxoid variant (FMNA), characterized by spindled cells in myxoid stroma, presents additional diagnostic challenges due to its rarity and overlapping features with renal cell carcinoma (RCC). A 72-year-old man with a history of nephrolithiasis and no prior urologic surgery was evaluated for a right renal mass. Fine-needle aspiration yielded cloudy red fluid with scant epithelial cells and a fibromyxoid background. Immunohistochemistry showed positivity for PAX8, AMACR, CK7, and CA-IX, leading to a pre-operative diagnosis of RCC. Partial nephrectomy revealed a unilocular cyst with a solid component. Histology demonstrated fibromyxoid stroma with embedded spindled cells and focal tubular NA features; therefore, a final diagnosis of fibromyxoid nephrogenic adenoma was rendered. Fibromyxoid nephrogenic adenoma is a benign entity that can closely mimic RCC on cytologic and immunohistochemical grounds. Our findings underscore the diagnostic pitfalls in small-volume cytologic samples. Awareness of the cytologic features of FMNA and cautious interpretation of immunostains are essential to avoid misdiagnosis and unnecessary treatment.

    View details for DOI 10.1002/dc.70167

    View details for PubMedID 42366464

  • Metastatic Gastrointestinal Stromal Tumor to the Scalp: A Case Report Highlighting Diagnostic Challenges and Molecular Correlation JOURNAL OF CUTANEOUS PATHOLOGY Sanchez, A. C., Shiyanbola, O. O., Qian, X., Yan, D., Sheahon, K. M., Wang, J. Y., Novoa, R. A., Rieger, K. E., Brown, R. A. 2025

    Abstract

    Gastrointestinal stromal tumors (GISTs) are rare gastrointestinal mesenchymal neoplasms. While the liver and peritoneum are the most common metastatic sites, skin involvement is rare. Nevertheless, recognizing skin metastases is crucial as it guides targeted treatment and indicates the possibility of widespread disease. Skin metastases pose diagnostic challenges due to histopathologic and clinical variability, often resembling other tumors. We present an 81-year-old female with metastatic GIST involving the scalp with corroborative molecular data. This case underscores the fundamental nature of clinicopathologic correlation and the role of molecular analysis in aiding diagnosis, guiding treatment decisions, and revealing the prognostic implications of rare metastatic patterns of GISTs.

    View details for DOI 10.1111/cup.14829

    View details for Web of Science ID 001512359600001

    View details for PubMedID 40542689

  • Cytologic diagnosis of fumarate hydratase-deficient renal cell carcinoma: A single-institutional experience. Cancer cytopathology Mullane, P. C., Qian, X., Lau, H. D., Lowe, A. C. 2025; 133 (2): e22931

    Abstract

    Fumarate hydratase-deficient renal cell carcinoma (FHRCC) is an aggressive carcinoma that typically presents as advanced-stage disease. Prompt recognition of FHRCC is critical for appropriate clinical care and genetic counseling for patients and family members. However, diagnosing FHRCC from cytology specimens is challenging, with limited characterization and no reports describing prospectively identified cases.Cytology fine-needle aspiration (FNA) cases diagnosed as FHRCC were reviewed, including two prospectively identified cases.Five cases of FHRCC diagnosed by FNA cytology were identified in five unique patients. The cytologic samples included four FNAs with core biopsy and one FNA with cell block. Biopsy sites included kidney (n = 1), chest wall (n = 1), omentum (n = 1), lung (n = 1), and cervical lymph node (n = 1). All cases demonstrated cytologically malignant epithelial cells characterized by enlarged, round nuclei with variable pleomorphism, irregular nuclear membranes, prominent nucleoli, and moderate-to-abundant amounts of cytoplasm. Perinucleolar halos characterized by chromatin margination and pallor around macronucleoli were seen in all cases. Cytologic features not previously described included cytoplasmic macrovacuoles and eosinophilic globules, cytophagocytosis, and floral groups. Papillary architecture was rarely present on aspirate smears. Cell block sections showed variable architectural patterns. By immunohistochemistry, FH was definitively lost in three of five cases (60%), and 2-succinocysteine was positive in all 5 cases (100%).Cytologic specimens of FHRCC demonstrate salient cytomorphologic features that can support their initial diagnosis. Confirmatory immunohistochemical testing using a dual panel of fumarate hydratase and 2-succinocysteine is recommended for the diagnosis in limited biopsy samples.

    View details for DOI 10.1002/cncy.22931

    View details for PubMedID 39804329

  • CHRNA6 RNA in situ hybridization is a useful tool for the diagnosis of extraskeletal myxoid chondrosarcoma. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc Dulken, B. W., Kingsley, L., Zdravkovic, S., Cespedes, O., Qian, X., Suster, D. I., Charville, G. W. 2024: 100464

    Abstract

    Extraskeletal myxoid chondrosarcoma (EMC) is an uncommon mesenchymal neoplasm characteristically composed of uniform-appearing round to spindle-shaped cells with eosinophilic cytoplasm and abundant myxoid extracellular matrix. While the majority of cases harbor a pathognomonic t(9;22) translocation that fuses EWSR1 with the orphan nuclear receptor NR4A3, there are less common variants that partner NR4A3 with TAF15, TCF12, or TFG. By immunohistochemistry, EMC has features of both cartilaginous and neuroendocrine differentiation, as evidenced by inconsistent expression of S100 protein and synaptophysin or INSM1, respectively, in a subset of cases. Given the limitations of available immunohistochemical stains for the diagnosis of EMC, we analyzed genome-wide gene expression microarray data to identify candidate biomarkers based on differential expression in EMC in comparison to other mesenchymal neoplasms. This analysis pointed to CHRNA6 as the gene with the highest relative expression in EMC (96-fold; P = 8.2×10-26), and the only gene with more than 50-fold increased expression in EMC compared to other tumors. Using RNA chromogenic in situ hybridization (CISH), we observed strong and diffuse expression of CHRNA6 in 25 cases of EMC, including both EWSR1- and TAF15-rearranged variants. All examined cases of histological mimics were negative for CHRNA6 overexpression; however, limited CHRNA6 expression, not reaching a threshold of greater than 5 puncta or one aggregate of chromogen in more than 25% of cells, was observed in 69 of 685 mimics (10.1%), spanning an array of mesenchymal tumors. Taken together, these findings suggest that, with careful interpretation and the use of appropriate thresholds, CHRNA6 RNA CISH is a potentially useful ancillary histological tool for the diagnosis of EMC.

    View details for DOI 10.1016/j.modpat.2024.100464

    View details for PubMedID 38447752

  • Pitfalls in soft tissue cytopathology. Cytopathology : official journal of the British Society for Clinical Cytology Rekhi, B., Qian, X., Domanski, H. A., Klijanienko, J., Field, A. 2023

    Abstract

    Fine needle aspiration biopsy (FNAB) is a diagnostic modality for the evaluation of suspicious soft tissue masses. Despite its reasonable sensitivity, specificity and positive predictive value in differentiating benign from malignant neoplasms, the exact subtyping of the primary soft tissue tumours can be challenging. Certain tumours constitute "pitfalls" and add to the diagnostic challenge. This review provides a detailed account of the diagnostic challenges in soft tissue cytopathology, including pitfalls and, more importantly, the ways to overcome these challenges by integrating clinical details, key cytomorphological features and judicious application of ancillary techniques.

    View details for DOI 10.1111/cyt.13282

    View details for PubMedID 37548096

  • The roles of the SWI/SNF complex in cancer CANCER CYTOPATHOLOGY Schaefer, I., Qian, X. 2023

    View details for DOI 10.1002/cncy.22691

    View details for Web of Science ID 000962646600001

    View details for PubMedID 37016486

  • Fine Needle Aspiration with Rapid on-site Evaluation in Diagnosing Retroperitoneal Masses: A Clinicopathological Analysis of 63 Cases Liu, Y., Lowe, A., Qian, X. ELSEVIER SCIENCE INC. 2023: S331
  • Molecular catastrophe, the peritoneal cavity and ovarian cancer prevention. The Journal of pathology Yoon, J. Y., Chapel, D., Goebel, E., Qian, X., Mito, J., Horowitz, N., Miron, A., Soong, T. R., Xian, W., Crum, C. P. 2022

    Abstract

    The current theory of carcinogenesis for the deadliest of "ovarian" cancers - high-grade serous carcinoma (HGSC) - holds that the malignancy develops first in the fallopian tube and spreads to the ovaries, peritoneum and/or regional lymph nodes. This is based primarily on the observation of early forms of serous neoplasia (serous tubular intraepithelial lesions (STILs), and serous tubular intraepithelial carcinomas (STICS)) in the fimbria of women undergoing risk reduction surgery. However, these lesions are uncommon in the general population, confer a low risk (5%) of HGSC following their removal in at-risk women with germ-line BRCA1/2 mutations and require 4 or more years to recur as intraperitoneal HGSC. These features suggest that isolated STILs and STICs behave as precursors with uncertain cancer risk rather than carcinomas. Their evolution to HGSC after escape from the tube could proceed step-wise with multiple biologic events; however, it is unclear whether immediately adjacent HGSCs in the setting of advanced disease evolved in the same fashion. The latter scenario could also be explained by a "catastrophic" model in which STICs suddenly develop with invasive and metastatic potential, overwhelming or obscuring the site of origin. Moreover, a similar model might explain the sudden emergence of HGSC in the peritoneal cavity following escape of precursor cells years before. Long term follow-up data from opportunistic or prophylactic salpingectomy should shed light on where malignant transformation occurs, as well as the time-line from precursor to metastatic HGSC. This article is protected by copyright. All rights reserved.

    View details for DOI 10.1002/path.5891

    View details for PubMedID 35238033

  • Fine-needle aspiration of soft tissue perineurioma: A comparative analysis of cytomorphology and immunohistochemistry with benign and malignant mimics CANCER CYTOPATHOLOGY Yang, E. J., Hornick, J. L., Qian, X. 2016; 124 (9): 651-658

    Abstract

    Soft tissue perineurioma (STP) is a benign peripheral nerve sheath tumor demonstrating uniform perineurial cell differentiation. To the authors' knowledge, the cytomorphologic features of STP remain incompletely characterized, and the distinction between STP and its benign (intramuscular/cellular myxoma) and malignant (low-grade fibromyxoid sarcoma [LGFMS]) mimics is challenging.Fine-needle aspiration (FNA)/core needle biopsies of 25 low-grade myxoid spindle cell neoplasm cases including STP (5 cases), intramuscular/cellular myxoma (16 cases), and LGFMS (4 cases) were reviewed retrospectively for cytomorphologic and immunophenotypic comparison.FNA smears of STP were hypocellular with scattered clusters of spindle cells with bland, slender nuclei; bipolar cytoplasmic processes; and scant myxoid to collagenous matrix. STP commonly lacked the abundant granular myxoid matrix material present in intramuscular/cellular myxoma (20% in STP vs 75% in intramuscular/cellular myxoma; P <.05), but these tumors were otherwise remarkably found to be similar on FNA smears. All STP and intramuscular/cellular myxoma cases lacked cytologic atypia, whereas 50% of LGFMS cases demonstrated mild nuclear atypia. EMA was positive in all STPs, but also was found to be at least focally positive in 60% of intramuscular/cellular myxoma cases (9 of 15 cases) and 75% of LGFMS cases (3 of 4 cases). MUC4 was found to be negative in all 15 intramuscular/cellular myxoma and 5 STP cases, but was positive in all 4 LGFMS cases.STP, intramuscular/cellular myxoma, and LGFMS have significant cytomorphologic overlap. Immunohistochemical staining with EMA is not beneficial due to a lack of specificity. Negative MUC4 staining reliably excludes LGFMS. Therefore, a clinically meaningful approach to the FNA biopsy evaluation of a low-grade myxoid spindle cell neoplasm is to provide a differential diagnosis and to exclude a low-grade sarcoma. Cancer Cytopathol 2016;124:651-8. © 2016 American Cancer Society.

    View details for DOI 10.1002/cncy.21725

    View details for Web of Science ID 000383685600008

    View details for PubMedID 27159449